Page last updated: 2024-11-02

fenclonine and Bile Duct Cancer

fenclonine has been researched along with Bile Duct Cancer in 1 studies

Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.

Research Excerpts

ExcerptRelevanceReference
"Cholangiocarcinoma is a devastating cancer of biliary origin with limited treatment options."1.35Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. ( Alpini, G; Alvaro, D; Benedetti, A; Bernuzzi, F; Coufal, M; DeMorrow, S; Frampton, G; Franchitto, A; Gaudio, E; Invernizzi, P; Kopriva, S; Lee, SP; Marzioni, M; Onori, P; Venter, J, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alpini, G1
Invernizzi, P1
Gaudio, E1
Venter, J1
Kopriva, S1
Bernuzzi, F1
Onori, P1
Franchitto, A1
Coufal, M1
Frampton, G1
Alvaro, D1
Lee, SP1
Marzioni, M1
Benedetti, A1
DeMorrow, S1

Other Studies

1 other study available for fenclonine and Bile Duct Cancer

ArticleYear
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth.
    Cancer research, 2008, Nov-15, Volume: 68, Issue:22

    Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Chromo

2008